Dr. Josep Tabernero

Head of the Medical Oncology Department at the Vall d’Hebron University Hospital, Director of the Vall d’Hebron Institute of Oncology (VHIO) and Professor of Medicine at UVic.
Principal Investigator of several Phase I pharmacodynamic studies and translational projects with tumor-directed targeted therapies and immune therapies.
Serves on the Editorial Boards of various top tier journals including Annals of Oncology, ESMO Open, Cancer Discovery, Clinical Cancer Research, Cancer Treatment Reviews and Nature Reviews in Clinical Oncology.
He has (co) authored approximately 500 peer-reviewed papers.
Previously, he was the President of the European Society for Medical Oncology (ESMO) for the term 2018-2019,
Active member of the American- Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO).
He has also been a member of the Educational and Scientific Committees of the ESMO, ECCO, ASCO, AACR, AACR/NCI/EORTC, ASCO Gastrointestinal, TAT and WCGIC meetings.
Holds MD and PhD degrees from the Universitat Autònoma de Barcelona, Spain